Alamar Biosciences News and Activities

Acquisition, funding and merger involving Alamar Biosciences.

• Alamar Biosciences is now listed under ticker ALMR. (posted on April 21 2026).
• Alamar Biosciences has just announced a $191 Million fundraising (posted on April 17 2026).

View the org chart displaying its 27 main executives

Most searched biographies at Alamar Biosciences

• Yuling Luo, Chairman and Chief Executive Officer
• Rebecca Chambers, Director
• Frank Witney, Director

Popular executive movements at Alamar Biosciences

• Tod White, who was Chief Business Officer and Chief Financial Officer, is promoted to President  (posted on October 16 2025).
• Justin McAnear has joined the company as Chief Financial Officer  (posted on October 16 2025).

Create your alert
to follow the executive moves at Alamar Biosciences.

Alamar Biosciences has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Alamar Biosciences

• Proteomics Startup News: Alamar Biosciences Inc., Fremont, CA
• https://alamarbio.com/wp-content/uploads/2021/09/Alamar-Bio-Press-Release-9-8-21.pdf

Social media about Alamar Biosciences

• Alamar Biosciences on Wikipedia, Google News & Yahoo Finance
• Alamar Biosciences on LinkedIn, X (Twitter) & YouTube